|Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently|
M Leid, P Kastner, R Lyons, H Nakshatri, M Saunders, T Zacharewski, ...
Cell 68 (2), 377-395, 1992
|Phosphatidylinositol 3-Kinase/AKT-mediated activation of estrogen receptor α A new model for anti-estrogen resistance|
RA Campbell, P Bhat-Nakshatri, NM Patel, D Constantinidou, S Ali, ...
Journal of Biological Chemistry 276 (13), 9817-9824, 2001
|CD44+/CD24-breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis|
C Sheridan, H Kishimoto, RK Fuchs, S Mehrotra, P Bhat-Nakshatri, ...
Breast Cancer Research 8 (5), 1-13, 2006
|Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth.|
H Nakshatri, P Bhat-Nakshatri, DA Martin, RJ Goulet, GW Sledge
Molecular and cellular biology 17 (7), 3629-3639, 1997
|NF-κ B promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4|
G Helbig, KW Christopherson, P Bhat-Nakshatri, S Kumar, H Kishimoto, ...
Journal of biological chemistry 278 (24), 21631-21638, 2003
|NF-κ B represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2|
HL Chua, P Bhat-Nakshatri, SE Clare, A Morimiya, S Badve, H Nakshatri
Oncogene 26 (5), 711-724, 2007
|Cutting edge: IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production|
T Starnes, MJ Robertson, G Sledge, S Kelich, H Nakshatri, HE Broxmeyer, ...
The Journal of Immunology 167 (8), 4137-4140, 2001
|Promoter context-and response element-dependent specificity of the transcriptional activation and modulating functions of retinoic acid receptors|
S Nagpal, M Saunders, P Kastner, B Durand, H Nakshatri, P Chambon
Cell 70 (6), 1007-1019, 1992
|RARs and RXRs: evidence for two autonomous transactivation functions (AF‐1 and AF‐2) and heterodimerization in vivo.|
S Nagpal, S Friant, H Nakshatri, P Chambon
The EMBO journal 12 (6), 2349-2360, 1993
|Paclitaxel sensitivity of breast cancer cells with constitutively active NF-κB is enhanced by IκBα super-repressor and parthenolide|
NM Patel, S Nozaki, NH Shortle, P Bhat-Nakshatri, TR Newton, S Rice, ...
Oncogene 19 (36), 4159-4169, 2000
|Estradiol-regulated microRNAs control estradiol response in breast cancer cells|
P Bhat-Nakshatri, G Wang, NR Collins, MJ Thomson, TR Geistlinger, ...
Nucleic acids research 37 (14), 4850-4861, 2009
|FOXA1 expression in breast cancer—correlation with luminal subtype A and survival|
S Badve, D Turbin, MA Thorat, A Morimiya, TO Nielsen, CM Perou, ...
Clinical cancer research 13 (15), 4415-4421, 2007
|A retinoic acid response element is present in the mouse cellular retinol binding protein I (mCRBPI) promoter.|
WC Smith, H Nakshatri, P Leroy, J Rees, P Chambon
The EMBO Journal 10 (8), 2223-2230, 1991
|Mouse retinoic acid receptor alpha 2 isoform is transcribed from a promoter that contains a retinoic acid response element|
P Leroy, H Nakshatri, P Chambon
Proceedings of the National Academy of Sciences 88 (22), 10138-10142, 1991
|PROGgeneV2: enhancements on the existing database|
CP Goswami, H Nakshatri
BMC cancer 14 (1), 1-6, 2014
|Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment|
E Resetkova, JS Reis-Filho, RK Jain, R Mehta, MA Thorat, H Nakshatri, ...
Breast cancer research and treatment 123 (1), 97-108, 2010
|Nuclear factor-κB is constitutively activated in prostate cancer in vitro and is overexpressed in prostatic intraepithelial neoplasia and adenocarcinoma of the prostate|
C Sweeney, L Li, R Shanmugam, P Bhat-Nakshatri, V Jayaprakasan, ...
Clinical Cancer Research 10 (16), 5501-5507, 2004
|The sesquiterpene lactone parthenolide in combination with docetaxel reduces metastasis and improves survival in a xenograft model of breast cancer|
CJ Sweeney, S Mehrotra, MR Sadaria, S Kumar, NH Shortle, Y Roman, ...
Molecular cancer therapeutics 4 (6), 1004-1012, 2005
|Cloning of BRAK, a novel divergent CXC chemokine preferentially expressed in normal versus malignant cells|
R Hromas, HE Broxmeyer, C Kim, H Nakshatri, K Christopherson II, ...
Biochemical and biophysical research communications 255 (3), 703-706, 1999
|Identity profiling of cell surface markers by multiplex gold nanorod probes|
C Yu, H Nakshatri, J Irudayaraj
Nano letters 7 (8), 2300-2306, 2007